ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | Apr 01, 2024 | Sale | $28.03 | 6,000 | 168,180 | 204,851 | Apr 03, 2024, 06:05 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Director | Mar 18, 2024 | Buy | $27.49 | 1,000 | 27,490 | 31,680 | Mar 20, 2024, 07:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Director | Mar 19, 2024 | Buy | $28.00 | 1,000 | 28,000 | 32,680 | Mar 20, 2024, 07:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Lu Hongbo | Director | Mar 20, 2024 | Buy | $27.50 | 1,000 | 27,500 | 33,680 | Mar 20, 2024, 07:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Mar 06, 2024 | Sale | $35.19 | 40,000 | 1,407,600 | 400,600 | Mar 08, 2024, 05:54 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jan 31, 2024 | Option Exercise | $23.44 | 114,998 | 2,696,055 | 3,772,547 | Feb 02, 2024, 05:25 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | Jan 12, 2024 | Sale | $36.89 | 7,940 | 292,904 | 214,553 | Jan 17, 2024, 06:32 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Jan 11, 2024 | Sale | $38.06 | 2,911 | 110,788 | 130,811 | Jan 16, 2024, 06:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 11, 2024 | Sale | $38.07 | 3,934 | 149,759 | 49,170 | Jan 16, 2024, 06:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Director | Jan 11, 2024 | Sale | $38.06 | 3,147 | 119,787 | 61,778 | Jan 16, 2024, 06:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Director | Jan 11, 2024 | Sale | $38.10 | 4,720 | 179,813 | 33,101 | Jan 16, 2024, 06:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Officer | Jan 05, 2024 | Sale | $33.89 | 74 | 2,508 | 136,501 | Jan 08, 2024, 05:17 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Jan 05, 2024 | Sale | $35.27 | 16,104 | 567,910 | 455,304 | Jan 08, 2024, 05:16 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | Jan 05, 2024 | Sale | $35.26 | 8,303 | 292,804 | 206,000 | Jan 08, 2024, 05:16 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | Jan 03, 2024 | Sale | $32.19 | 6,300 | 202,781 | 178,734 | Jan 05, 2024, 08:02 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | Jan 05, 2024 | Sale | $35.18 | 32,143 | 1,130,748 | 249,134 | Jan 05, 2024, 08:02 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | Jan 03, 2024 | Sale | $32.28 | 8,749 | 282,439 | 408,726 | Jan 05, 2024, 07:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | Jan 04, 2024 | Sale | $32.63 | 1,600 | 52,208 | 402,226 | Jan 05, 2024, 07:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | Jan 05, 2024 | Sale | $35.27 | 22,841 | 805,716 | 485,326 | Jan 05, 2024, 07:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jan 02, 2024 | Sale | $31.01 | 9,952 | 308,637 | 3,720,366 | Jan 04, 2024, 05:25 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 20, 2023 | Sale | $28.54 | 12,000 | 342,480 | 3,725,000 | Dec 22, 2023, 05:04 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 65,825 | Dec 19, 2023, 04:03 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 114,754 | Dec 19, 2023, 03:55 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 22,854 | Dec 19, 2023, 03:54 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 36,721 | Dec 19, 2023, 03:52 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 132,622 | Dec 19, 2023, 03:51 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 51,804 | Dec 19, 2023, 03:41 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | Nov 20, 2023 | Sale | $28.80 | 19,700 | 567,315 | 136,742 | Nov 22, 2023, 02:31 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 25, 2023 | Sale | $24.21 | 24,338 | 589,223 | 3,737,000 | Oct 27, 2023, 06:23 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Vakiener Victoria | Director | Sep 28, 2023 | Sale | $26.33 | 1,550 | 40,811 | 21,734 | Oct 02, 2023, 05:51 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 18, 2023 | Sale | $16.44 | 115,510 | 1,898,559 | 3,819,093 | Sep 20, 2023, 06:10 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Officer | Jul 03, 2023 | Sale | $35.31 | 8,925 | 315,142 | 61,575 | Jul 06, 2023, 06:04 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | Jun 30, 2023 | Sale | $35.53 | 3,000 | 106,590 | 188,484 | Jul 05, 2023, 06:15 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Jun 27, 2023 | Sale | $36.20 | 15,000 | 543,000 | 381,704 | Jun 29, 2023, 06:41 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | May 05, 2023 | Sale | $40.90 | 6,500 | 265,850 | 117,635 | May 08, 2023, 06:29 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | May 04, 2023 | Sale | $20.76 | 100,000 | 2,076,292 | 3,811,338 | May 05, 2023, 07:04 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | May 03, 2023 | Option Exercise | $20.57 | 109,856 | 2,260,287 | 3,816,266 | May 05, 2023, 07:04 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Director | Mar 03, 2023 | Sale | $32.65 | 11,350 | 370,578 | 7,867 | Mar 06, 2023, 06:04 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Feb 27, 2023 | Sale | $32.62 | 875 | 28,542 | 13,000 | Mar 01, 2023, 06:14 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 09, 2023 | Sale | $30.00 | 3,200 | 96,000 | 28,950 | Jan 11, 2023, 08:23 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | Jan 05, 2023 | Sale | $37.39 | 15,000 | 560,850 | 420,875 | Jan 06, 2023, 07:30 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | Jan 05, 2023 | Sale | $37.40 | 13,803 | 516,232 | 198,057 | Jan 06, 2023, 07:24 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | COO and General Counsel | Jan 03, 2023 | Sale | $38.33 | 17,500 | 670,802 | 378,222 | Jan 05, 2023, 07:10 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Chief Discovery/Trans Medicine | Jan 03, 2023 | Sale | $38.38 | 10,338 | 396,738 | 154,431 | Jan 05, 2023, 07:05 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Dec 29, 2022 | Sale | $40.00 | 30,625 | 1,225,000 | 336,704 | Dec 30, 2022, 05:12 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | Dec 21, 2022 | Option Exercise | $6.15 | 32,000 | 196,800 | 380,875 | Dec 22, 2022, 08:01 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | Nov 21, 2022 | Sale | $29.99 | 19,500 | 584,738 | 91,700 | Nov 22, 2022, 06:05 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Sep 27, 2022 | Option Exercise | $30.79 | 40,624 | 1,250,679 | 3,469,856 | Sep 29, 2022, 05:15 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jul 07, 2022 | Option Exercise | $14.54 | 2,501 | 36,365 | 4,060,135 | Jul 11, 2022, 08:08 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Feb 11, 2022 | Sale | $28.55 | 292,776 | 8,358,618 | 4,204,022 | Feb 14, 2022, 08:54 AM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Jan 07, 2022 | Option Exercise | $5.19 | 11,806 | 61,273 | 4,057,634 | Jan 07, 2022, 09:39 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | Jan 05, 2022 | Sale | $61.72 | 32,500 | 2,005,875 | 368,941 | Jan 07, 2022, 08:16 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Jan 05, 2022 | Sale | $61.70 | 40,000 | 2,467,941 | 488,097 | Jan 06, 2022, 08:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Senior Vice President | Jan 04, 2022 | Sale | $65.49 | 19,375 | 1,268,818 | 171,295 | Jan 06, 2022, 08:56 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Senior Vice President | Jan 05, 2022 | Sale | $61.72 | 6,250 | 385,773 | 159,585 | Jan 06, 2022, 08:56 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 03, 2022 | Sale | $64.72 | 4,500 | 291,244 | 28,150 | Jan 04, 2022, 09:35 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Director | Jan 03, 2022 | Sale | $64.75 | 4,050 | 262,233 | 7,110 | Jan 04, 2022, 09:33 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Director | Jan 03, 2022 | Sale | $64.71 | 4,500 | 291,177 | 19,256 | Jan 04, 2022, 09:31 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Jan 03, 2022 | Sale | $64.71 | 4,500 | 291,192 | 87,372 | Jan 04, 2022, 09:30 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | Dec 31, 2021 | Option Exercise | $6.15 | 28,000 | 172,200 | 321,375 | Jan 04, 2022, 09:26 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Dec 28, 2021 | Buy | $66.37 | 655 | 43,472 | 109,868 | Dec 29, 2021, 08:44 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Director | Dec 28, 2021 | Sale | $66.82 | 3,400 | 227,188 | 36,571 | Dec 29, 2021, 08:41 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 23, 2021 | Option Exercise | $5.19 | 11,806 | 61,273 | 3,245,828 | Dec 23, 2021, 09:52 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 15, 2021 | Sale | $67.56 | 60,000 | 4,053,431 | 3,253,165 | Dec 17, 2021, 08:14 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | Nov 19, 2021 | Sale | $69.31 | 19,500 | 1,351,589 | 116,796 | Nov 22, 2021, 04:56 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 20, 2021 | Sale | $66.23 | 15,000 | 993,450 | 3,329,022 | Oct 22, 2021, 05:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 22, 2021 | Sale | $65.63 | 50,000 | 3,281,532 | 3,284,852 | Oct 22, 2021, 05:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | OLUKOTUN ADEOYE Y | Director | Sep 13, 2021 | Sale | $63.76 | 5,000 | 318,800 | 11,750 | Sep 14, 2021, 05:25 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Sep 09, 2021 | Sale | $65.24 | 5,000 | 326,200 | 109,868 | Sep 10, 2021, 04:53 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Director | Jun 24, 2021 | Sale | $89.85 | 5,000 | 449,250 | 21,500 | Jun 25, 2021, 06:59 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hassard James | Chief Commercial Officer | Jun 22, 2021 | Sale | $89.22 | 3,625 | 323,423 | 105,750 | Jun 24, 2021, 06:44 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Feb 22, 2021 | Sale | $88.73 | 1,125 | 99,821 | 13,875 | Feb 24, 2021, 06:51 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | Feb 08, 2021 | Sale | $46.84 | 180,000 | 8,431,040 | 383,375 | Feb 10, 2021, 05:56 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Jan 15, 2021 | Sale | $83.28 | 3,000 | 249,840 | 12,500 | Jan 19, 2021, 05:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Senior Vice President | Jan 14, 2021 | Sale | $81.29 | 10,000 | 812,942 | 130,064 | Jan 15, 2021, 05:49 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Jan 11, 2021 | Sale | $81.02 | 11,597 | 939,589 | 445,446 | Jan 12, 2021, 06:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Jan 12, 2021 | Sale | $81.00 | 1,441 | 116,721 | 444,005 | Jan 12, 2021, 06:06 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hassard James | Chief Commercial Officer | Jan 07, 2021 | Sale | $75.00 | 15,625 | 1,171,875 | 109,375 | Jan 08, 2021, 06:05 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | O'Brien Patrick | General Counsel | Jan 06, 2021 | Sale | $72.41 | 25,000 | 1,810,346 | 317,233 | Jan 07, 2021, 06:11 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Jan 06, 2021 | Sale | $72.44 | 30,625 | 2,218,477 | 486,568 | Jan 07, 2021, 06:08 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Senior Vice President | Jan 05, 2021 | Sale | $72.53 | 19,375 | 1,405,303 | 171,200 | Jan 07, 2021, 06:02 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Hamilton James C | Senior Vice President | Jan 06, 2021 | Sale | $72.48 | 19,375 | 1,404,276 | 154,925 | Jan 07, 2021, 06:02 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | PERRY MICHAEL S | Director | Jan 04, 2021 | Sale | $76.09 | 4,000 | 304,360 | 90,000 | Jan 05, 2021, 06:14 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Jan 04, 2021 | Sale | $76.08 | 4,000 | 304,320 | 119,368 | Jan 05, 2021, 06:11 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 04, 2021 | Sale | $76.08 | 3,750 | 285,300 | 30,250 | Jan 05, 2021, 06:01 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 18, 2020 | Option Exercise | $5.73 | 40,510 | 232,006 | 2,545,747 | Dec 22, 2020, 05:55 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Dec 17, 2020 | Sale | $79.30 | 9,075 | 719,648 | 114,738 | Dec 18, 2020, 06:26 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | GIVEN DOUGLAS B | Director | Dec 17, 2020 | Sale | $79.59 | 500 | 39,795 | 15,000 | Dec 18, 2020, 06:26 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Dec 10, 2020 | Sale | $71.26 | 3,000 | 213,780 | 26,800 | Dec 11, 2020, 06:16 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 08, 2020 | Sale | $34.99 | 32,648 | 1,142,354 | 2,521,561 | Dec 10, 2020, 07:07 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Dec 09, 2020 | Sale | $35.53 | 77,352 | 2,748,544 | 2,543,913 | Dec 10, 2020, 07:07 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Bradshaw Curt | Chief Scientific Officer | Nov 19, 2020 | Sale | $69.39 | 15,625 | 1,084,219 | 15,625 | Nov 23, 2020, 05:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Bradshaw Curt | Chief Scientific Officer | Nov 20, 2020 | Sale | $68.73 | 15,625 | 1,073,906 | 0 | Nov 23, 2020, 05:58 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | San Martin Javier | Chief Medical Officer | Nov 19, 2020 | Sale | $69.39 | 19,500 | 1,353,105 | 130,500 | Nov 20, 2020, 06:03 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Nov 09, 2020 | Option Exercise | $41.96 | 87,010 | 3,650,633 | 471,173 | Nov 12, 2020, 05:49 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | De Backer Marianne | Director | Oct 08, 2020 | Buy | $50.47 | 1,000 | 50,465 | 17,500 | Oct 26, 2020, 06:02 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Oct 23, 2020 | Sale | $58.21 | 100,000 | 5,821,032 | 2,517,509 | Oct 23, 2020, 07:35 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Myszkowski Kenneth Allen | Chief Financial Officer | Oct 20, 2020 | Option Exercise | $30.10 | 58,332 | 1,755,502 | 456,834 | Oct 22, 2020, 06:02 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Ferrari Mauro | Director | Oct 09, 2020 | Sale | $48.00 | 10,000 | 480,000 | 30,971 | Oct 13, 2020, 06:01 PM |
ARWR | | ARROWHEAD PHARMACEUTICALS, INC. | Anzalone Christopher Richard | Chief Executive Officer | Aug 13, 2020 | Sale | $25.62 | 100,000 | 2,562,500 | 2,655,237 | Aug 14, 2020, 06:08 PM |